Shandong Keyuan Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 224.16 million compared to CNY 223.59 million a year ago. Revenue was CNY 224.47 million compared to CNY 224.17 million a year ago.

Net income was CNY 51.2 million compared to CNY 51.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.5404 compared to CNY 0.6289 a year ago. Diluted earnings per share from continuing operations was CNY 0.5404 compared to CNY 0.6289 a year ago.